Abbott Labs President/COO Parkinson to retire
CHICAGO, July 28 (Reuters) - Abbott Laboratories said on Friday that Robert Parkinson Jr., president and chief operating officer, will step down on Aug. 1 and will be succeeded by a three-person leadership team.
The new leadership structure is designed to provide strategic and leadership focus in the core areas of pharmaceuticals, medical products and Ross Products, Abbott (NYSE:ABT - news) said.
Parkinson will serve in an advisory role until his retirement on Jan. 31, 2001, the company said.
The leadership team will include:
-- Jeffrey Leiden, 44. He will be appointed executive vice president-pharmaceuticals. He will retain the title and responsibilities of chief scientific officer and will report to Abbott Chairman and Chief Executive Miles White.
-- Richard Gonzalez, 46. He will be appointed executive vice president-medical products, reporting to White.
-- Joy A. Amundson, 45. He is currently senior vice president-Ross Products and will continue to head that unit.
``This new leadership model is part of a long-term strategic plan to provide strong scientific focus across our businesses,''White said in a statement. ``It provides better alignment both strategically and scientifically for our core pharmaceutical businesses and at the same time provides focused leadership for our medical products businesses.''
Parkinson is retiring after nearly 25 years at Abbott.
market seems to like this and after all the stuff that's been going on in the plants, offices and facilities, seems like good news...new blood...
they got the stuff...just a matter of how they handle the other aspects of the biz...
chris |
